Consolidated Financial Results
for the Six Months Ended December 31, 2021
[Japanese GAAP]
January 31, 2022
Company name: OLBA HEALTHCARE HOLDINGS, Inc.
Stock exchange listing: Tokyo Stock Exchange
Code number: 2689
URL: https://www.olba.co.jp/
Representative: Yohei Maeshima, President CEO
Contact: Nobuharu Murata, Managing Director and General Manager, Administrative Department
Phone: +81-86-236-1115
Scheduled date of filing quarterly securities report: February 14, 2022
Scheduled date of commencing dividend payments: Availability of supplementary briefing material on quarterly financial results: Unavailable
Schedule of quarterly financial results briefing session: Scheduled (for securities analysts)(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Six Months Ended December 31, 2021 (July 1, 2021 to
December 31, 2021)(1) Consolidated Operating Results(% indicates changes from the previous year.)
Net income
Net sales
Operating income
Ordinary income
attributable toowners of parent
Six months ended
Million yen%
Million yen%
Million yen%
Million yen%
December 31, 2021
53,0306.4786
26.780230.5532
36.9
December 31, 2020
49,861
－620
85.2
615
86.6
389
129.7
(Note) Comprehensive income: Six months ended December 31, 2021: ¥534 million [37.2%]
Six months ended December 31, 2020: ¥389 million [246.3%]
Basic earnings
per share

Diluted earnings
per share

Six months ended
YenYenDecember 31, 2021
87.57－
December 31, 2020
63.98－(Note) Effective the beginning of the fiscal year ending June 30, 2022, the Company began applying the AccountingStandard for Revenue Recognition (ASBJ Statement No. 29, March 31, 2020) and other standards. In accordancewith the principle-based treatment of the standards, the consolidated operating results for the fiscal year ended
June 30, 2021 have been restated retroactively. The change in net sales for the six months ended December 31,
2020 are, therefore, not presented.
(2) Consolidated Financial Position
Total assets
Million yen

Net assets

Equity ratio

Million yen%

41,5828,331
As of December 31, 2021
36,5628,131
As of June 30, 2021
(Reference) Equity: As of December 31, 2021: ¥8,331 million
As of June 30, 2021: ¥8,131 million20.0
22.2

2. Dividends
Annual dividends
1stquarter-end

2ndquarter-end

3rdquarter-end

Yen

Yen

Yen

YenYen－

50.00

50.00

－

50.00

50.00

－
0.00
Fiscal year ended June 30, 2021－
0.00
Fiscal year ending June 30, 2022
Fiscal year ending June 30, 2022
(Forecast)(Note) Revision to the forecast for dividends announced most recently: None

Year-endTotal

3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 2022 (July 1, 2021 to June 30, 2022)(% indicates changes from the previous corresponding period.)
Net sales
Million yen%

Operating income

Ordinary income

Million yen

Million yen%

Net income
attributable toowners of parent% Million yen

Basic earnings
per share%

Yen

Full year
105,049 2.91,597 3.7
1,615 4.7
1,052
6.4
173.01(Note) Revision to the financial results forecast announced most recently: None(Note) Effective the beginning of the fiscal year ending June 30, 2022, the Company began applying the AccountingStandard for Revenue Recognition (ASBJ Statement No. 29, March 31, 2020) and other standards. Thosestandards have been reflected in the figures of the consolidated financial results forecast above. The changes in
net sales from the previous corresponding periods have been calculated by retroactively applying those standards
to the figures for the fiscal year ended June 30, 2021.
Notes:(1) Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting inchanges in scope of consolidation): None
Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name)(2) Accounting policies adopted specially for the preparation of quarterly consolidated financial statements: None
(3) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: Yes
2) Changes in accounting policies other than 1) above: None
3) Changes in accounting estimates: None
4) Retrospective restatement: None
(4) Total number of issued shares (common stock)1) Total number of issued shares at the end of the period (including treasury stock):
December 31, 2021: 6,250,000 shares
June 30, 2021: 6,250,000 shares2) Total number of treasury stock at the end of the period:
December 31, 2021: 163,476 shares
June 30, 2021: 167,676 shares
3) Average number of shares during the period:
Six months ended December 31, 2021: 6,084,724 shares
Six months ended December 31, 2020: 6,082,395 shares
As of December 31, 2021, 112,400 shares of the Company’s stock held by the Board Benefit Trust were included intreasury stock.

* Quarterly financial results are outside the scope of the quarterly review procedures conducted by a certified public
accountant or audit corporation.
* Explanation of the proper use of financial results forecast and other notes
The figures forecasted above are based on information that is available as of the date of publication of thisdocument, and contain a wide range of uncertain factors. Actual results may differ significantly from thesefigures due to factors such as changes in the business environment.

2. Quarterly Consolidated Financial Statements and Principal Notes(1) Quarterly Consolidated Balance Sheets(Thousand yen)
As of June 30, 2021
AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade
Notes and accounts receivable - trade, andcontract assets
Electronically recorded monetary claims operating
Merchandise
Other
Total current assets
Non-current assets
Property, plant and equipment
Intangible assets
Other
Total intangible assets
Investments and other assets
Total non-current assets
Total assets
Liabilities
Current liabilities
Notes and accounts payable - trade
Electronically recorded obligations - operating
Short-term borrowings
Income taxes payable
Provision for bonuses for directors (and otherofficers)
Provision for bonuses
Other
Total current liabilities
Non-current liabilities
Long-term borrowings
Provision for share awards for directors (andother officers)
Retirement benefit liability
Long-term accounts payable - other
Other
Total non-current liabilities
Total liabilities
Net assets
Shareholders' equity
Share capital
Capital surplus
Retained earnings
Treasury shares
Total shareholders' equity
Accumulated other comprehensive income
Valuation difference on available-for-salesecurities
Remeasurements of defined benefit plans
Total accumulated other comprehensive income
Non-controlling interests
Total net assets
Total liabilities and net assets

As of December 31, 2021

2,158,875
18,710,644

3,178,754-

21,938,334

2,246,521

2,705,180

5,431,149
557,800
29,104,992

5,868,825
510,596
34,201,690

4,653,580

4,663,632

698,501
698,501
2,104,991
7,457,073
36,562,066

747,904
747,904
1,969,221
7,380,758
41,582,449

16,304,571
6,824,412
520,000
524,874-

19,628,834
6,736,401
3,220,000
102,812
8,376

35,2901,909,551
26,118,699

35,3141,226,342
30,958,081

275,000
155,222

165,000
186,483

398,652
279,927
1,203,040
2,311,843
28,430,543

417,722
278,127
1,245,805
2,293,138
33,251,220

607,750
346,954
7,143,982(246,635)
7,852,050

607,750
315,704
7,366,879(240,155)
8,050,178

134,964

146,907

144,507279,472
8,131,522
36,562,066

134,143
281,050
8,331,228
41,582,449-

(2) Quarterly Consolidated Statements of Income and Comprehensive Income
Quarterly Consolidated Statements of Income
Six Months Ended December 31

Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Operating profit
Non-operating income
Interest income
Dividend income
Insurance claim incomeCommission income
Electricity sale income
Subsidy income
Share of profit of entities accounted for using
equity method
Other
Total non-operating income
Non-operating expenses
Interest expenses
Share of loss of entities accounted for using equity
methodElectricity sale expenses
Other
Total non-operating expenses
Ordinary profit
Extraordinary income
Gain on sale of property, plant and equipment
Total extraordinary income
Extraordinary losses
Loss on retirement of property, plant andequipment
Loss on sale of property, plant and equipment
Impairment losses
Total extraordinary losses
Profit before income taxes
Income taxes - current
Income taxes - deferred
Total income taxes
ProfitProfit attributable to non-controlling interests
Profit attributable to owners of parent

For the six months ended
December 31, 2020
49,861,455
44,222,338
5,639,116
5,018,304
620,812(Thousand yen)
For the six months ended
December 31, 2021
53,030,262
47,119,022
5,911,239
5,124,434
786,804

240
899
1,944
10,225
4,823
-

181
768
7,415
10,337
4,201
2,335
3,127

5,703
23,836

3,385
31,752

11,97011,022

10,656-

3,074
3,33829,406
615,242

2,890
2,368
15,916
802,641

784
784

3,834
3,834

824

2,379

824
615,202
128,058
97,968226,026
389,176
389,176

2,675
18,77023,825
782,649
78,236
171,570
249,806
532,843532,843

Quarterly Consolidated Statements of Comprehensive Income
Six Months Ended December 31

ProfitOther comprehensive income
Valuation difference on available-for-sale securities
Remeasurements of defined benefit plans, net of tax
Total other comprehensive income
Comprehensive income
Comprehensive income attributable toComprehensive income attributable to owners of parent
Comprehensive income attributable to non-controllinginterests

For the six months ended
December 31, 2020
389,176(Thousand yen)
For the six months ended
December 31, 2021
532,843

7,706(7,284)421
389,597

11,942(10,364)
1,578
534,421389,597

534,421--

(3) Quarterly Consolidated Statements of Cash Flows(Million yen)
For the six months ended
December 31, 2021

For the six months ended
December 31, 2020
Cash flows from operating activities
Profit before income taxes
Depreciation
Impairment losses
Increase (decrease) in allowance for doubtful accounts
Decrease (increase) in retirement benefit asset
Increase (decrease) in retirement benefit liability
Increase (decrease) in provision for share awards for
directors (and other officers)
Interest and dividend income
Interest expenses
Share of loss (profit) of entities accounted for using
equity method
Loss (gain) on sale of property, plant and equipment
Loss on retirement of property, plant and equipment
Decrease (increase) in trade receivables
Decrease (increase) in inventories
Increase (decrease) in trade payables
Increase (decrease) in long-term accounts payable other
Other, net
SubtotalInterest and dividends received
Interest paid
Income taxes paid
Income taxes refund
Net cash provided by (used in) operating activities
Cash flows from investing activities
Purchase of property, plant and equipment
Proceeds from sale of property, plant and equipment
Purchase of intangible assets
Purchase of investment securities
Other, net
Net cash provided by (used in) investing activities
Cash flows from financing activities
Net increase (decrease) in short-term borrowings
Repayments of long-term borrowings
Dividends paid
Repayments of lease obligations
Proceeds from sale and leaseback transactions
Purchase of shares of subsidiaries not resulting in change
in scope of consolidation
Net cash provided by (used in) financing activities
Effect of exchange rate change on cash and cash
equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

615,202
199,189607(2,202)
23,613

782,649
198,790
18,7701,012(13,895)
19,07030,886

31,260(1,140)11,970(949)
10,656

11,022(3,127)(784)
824(4,331,279)(665,334)
4,939,391(1,158)2,379(3,688,086)(437,675)
3,236,251(19,879)(1,800)(225,403)
586,685
1,715(12,847)(360,625)
22,410237,339(394,345)(240,196)
1,555(12,006)(645,492)
29,420(866,719)(76,354)850(217,234)
1(292,737)(235,072)
37,600(65,812)(15,000)(278,285)

1,800,000(195,000)(278,453)(84,264)-2,700,000(110,000)(309,387)(86,216)
1,738-(31,250)

1,242,282

2,164,883--

1,186,884
1,877,288
3,064,172

1,019,878
2,110,675
3,130,554